Biography

Download Curriculum Vitae

The focus of my research is developing novel treatments for progressive childhood brain tumors and reducing the long-term side effects of childhood brain tumor survivors. My research has consisted of leading both investigator-initiated clinical trials and leading and participating in multi-institutional consortium studies. My training and experience as a pediatric neuro-oncologist and childhood cancer survivorship specialist, as well as my leadership as the director of the childhood cancer survivors’ program and medical director of pediatric neuro-oncology program at UT Southwestern Medical Center gives me a unique perspective on the clinical and research challenges of both the treatment of childhood cancer and the long-term neurological side effects of cancer treatment.

Education

Medical School
UT Southwestern Medical School (1993)
Internship
Children's Health Dallas (1994), Pediatrics
Residency
Children's Health Dallas (1996), Pediatrics
Fellowship
Johns Hopkins School of Medicine (1999), Pediatric Hematology/oncology

Research Interest

  • Evaluation of quality of life and late effects of childhood cancer survivors
  • New therapies for childhood brain tumors

Publications

Featured Publications LegendFeatured Publications

Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
Warren KE, Vezina G, Krailo M, Springer L, Buxton A, Peer CJ, Figg WD, William-Hughes C, Kessel S, Fouladi M, Gajjar A, Bowers D, J Clin Oncol 2023 Jun 41 18 3374-3383
Phase II study of everolimus for recurrent or progressive pediatric ependymoma.
Bowers DC, Rajaram V, Karajannis MA, Gardner SL, Su JM, Baxter P, Partap S, Klesse LJ, Neurooncol Adv 2023 5 1 vdad011
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Gajjar A, Mahajan A, Abdelbaki M, Anderson C, Antony R, Bale T, Bindra R, Bowers DC, Cohen K, Cole B, Dorris K, Ermoian R, Franson A, Helgager J, Landi D, Lin C, Metrock L, Nanda R, Palmer J, Partap S, Plant A, Pruthi S, Reynolds R, Ruggieri P, Stearns D, Storm P, Wang A, Warren K, Whipple N, Zaky W, McMillian NR, Pluchino LA, J Natl Compr Canc Netw 2022 Dec 20 12 1339-1362
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY, Dhanda SK, Lin T, Sioson E, Vasilyeva A, Gudenas B, Tatevossian RG, Jia S, Neale G, Bowers DC, Hassall T, Partap S, Crawford JR, Chintagumpala M, Bouffet E, McCowage G, Broniscer A, Qaddoumi I, Armstrong G, Wright KD, Upadhyaya SA, Vinitsky A, Tinkle CL, Lucas J, Chiang J, Indelicato DJ, Sanders R, Klimo P, Boop FA, Merchant TE, Ellison DW, Northcott PA, Orr BA, Zhou X, Onar-Thomas A, Gajjar A, Robinson GW, Acta Neuropathol 2022 Aug
Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation: A Delphi Study.
Kenney LB, Ames BL, Huang MS, Yock T, Bowers DC, Nekhlyudov L, Williams D, Hudson MM, Ullrich NJ, Neurology 2022 Aug

Books

Featured Books Legend Featured Books

Honors & Awards

  • Favorite Oncology Professionals
    CureSearch for ChildrenÂ’s Cancer (2013-2013)
  • Best Pediatric Specialists/Doctors in Dallas
    D Magazine, 2010, 2011, 2013, 2017, 2018, 2021 (2010-2021)
  • Elected to the Society for Pediatric Research
    (2006-2023)
  • Outstanding Graduate in the College of Science, Texas A&M University
    (1989-1989)

Professional Associations/Affiliations

  • American Society of Clinical Oncology (1999-2023)
  • Children's Oncology Group (1999-2023)
  • Society for Neuro-Oncology (2000-2023)
  • Society for Pediatric Research (2006-2023)